Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PUBLICATION

This article was originally published in Clinica

Executive Summary

Technology for Industry, the UK consultancy specialising in micro- and nanotechnology (MNT), has published the 2005 edition of its MNT in Healthcare and Lifesciences market sector report. It includes a market overview, industry size and trends, and technological developments, featuring the following specialisms: cardiac pacemakers and implantable devices; blood pressure sensors; hearing aids and cochlear implants; blood analysis; catheters, endoscopes and minimally invasive surgery; drug delivery systems; DNA analysis and lab-on-a-chip; and MNT applications in sensors/actuators. The MNT market is already worth $5bn and is projected to grow to $11m within three years, the Ely, Cambridgeshire company (www.tfi-ltd.co.uk) believes.

You may also be interested in...



Breckenridge Eyes First Kyprolis Generic With FDA Approval

Towa’s US-based Breckenridge is aiming for exclusivity with its generic version of Amgen’s Kyprolis – developed with partner Natco Pharma – after obtaining one of the first approvals for several strengths of the treatment for relapsed or refractory multiple myeloma.

Nestlé Sees Importance Of Local Brands In ‘Fragmented’ VMS Market

As Nestlé continues to expand its presence in the VMS market it will not take a brand popular in one country and “force” that name on consumers in a different part of the world, says CEO Mark Schneider.

Lupin Gets Another First With Fostair

Lupin has claimed a first with a UK approval for a rival to Fostair. The Indian company has told Generics Bulletin that it is planning to roll out the Luforbec branded generic later this year.

Topics

UsernamePublicRestriction

Register

MT055359

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel